Conquest is a pioneering AI startup dedicated to transforming cancer therapy through advanced predictive modeling and biological data analysis. By leveraging cutting-edge deep learning methodologies and insights from physics, Conquest aims to uncover cancer vulnerabilities that traditional drug discovery methods often overlook. The company fosters a collaborative environment for AI engineers and biologists to work together on groundbreaking projects, thus redefining the landscape of oncology and beyond. Committed to excellence and bold innovation, Conquest is building a culture that values high performance and impactful results in the pursuit of better health outcomes.